- Home
- CTSO vs RGS Comparison
CTSO vs RGS Comparison
Compare CTSO & RGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTSO
- RGS
- Stock Information
- Founded
- CTSO 1997
- RGS 1922
- Country
- CTSO United States
- RGS United States
- Employees
- CTSO N/A
- RGS N/A
- Industry
- CTSO Medical/Dental Instruments
- RGS Other Consumer Services
- Sector
- CTSO Health Care
- RGS Consumer Discretionary
- Exchange
- CTSO Nasdaq
- RGS Nasdaq
- Market Cap
- CTSO 51.6M
- RGS 47.0M
- IPO Year
- CTSO N/A
- RGS 1991
- Fundamental
- Price
- CTSO $1.08
- RGS $18.34
- Analyst Decision
- CTSO Strong Buy
- RGS
- Analyst Count
- CTSO 3
- RGS 0
- Target Price
- CTSO $4.67
- RGS N/A
- AVG Volume (30 Days)
- CTSO 159.7K
- RGS 31.4K
- Earning Date
- CTSO 05-08-2025
- RGS 04-30-2025
- Dividend Yield
- CTSO N/A
- RGS N/A
- EPS Growth
- CTSO N/A
- RGS N/A
- EPS
- CTSO N/A
- RGS 40.46
- Revenue
- CTSO $37,739,531.00
- RGS $191,336,000.00
- Revenue This Year
- CTSO $9.20
- RGS N/A
- Revenue Next Year
- CTSO $11.64
- RGS N/A
- P/E Ratio
- CTSO N/A
- RGS $0.51
- Revenue Growth
- CTSO 1.80
- RGS N/A
- 52 Week Low
- CTSO $0.70
- RGS $3.87
- 52 Week High
- CTSO $1.61
- RGS $35.50
- Technical
- Relative Strength Index (RSI)
- CTSO 45.16
- RGS 38.89
- Support Level
- CTSO $0.99
- RGS $18.00
- Resistance Level
- CTSO $1.15
- RGS $19.93
- Average True Range (ATR)
- CTSO 0.08
- RGS 1.42
- MACD
- CTSO -0.02
- RGS -0.23
- Stochastic Oscillator
- CTSO 10.53
- RGS 32.38
About CTSO Cytosorbents Corporation
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales, Distributors/strategic partners, and Government segments. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.
About RGS Regis Corporation
Regis Corp owns, franchises, and operates beauty salons throughout North America and the United Kingdom. The company's locations provide salon products and services to the mass market, including haircutting, styling, and hair coloring. The vast majority of Regis' salons are in strip malls, shopping centers, and Wal-Mart stores in North America and serve price-conscious customers. The company derives the majority of its revenue from these locations. The sale of products also contributes a relatively significant percentage of total sales. Regis also operates a smaller portfolio of premium salons across North America and the U.K. The company's majority brands include SmartStyle, Cost Cutters, and Supercuts.